RAAS Inhibitors and Risk of Covid-19. Reply
- PMID: 33108107
- DOI: 10.1056/NEJMc2030446
RAAS Inhibitors and Risk of Covid-19. Reply
Comment on
-
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1. N Engl J Med. 2020. PMID: 32356627 Free PMC article.
-
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1. N Engl J Med. 2020. PMID: 32356628 Free PMC article.
-
RAAS Inhibitors and Risk of Covid-19.N Engl J Med. 2020 Nov 12;383(20):1991-1992. doi: 10.1056/NEJMc2030446. Epub 2020 Oct 27. N Engl J Med. 2020. PMID: 33108103 No abstract available.
-
RAAS Inhibitors and Risk of Covid-19.N Engl J Med. 2020 Nov 12;383(20):1992. doi: 10.1056/NEJMc2030446. Epub 2020 Oct 27. N Engl J Med. 2020. PMID: 33108104 No abstract available.
-
RAAS Inhibitors and Risk of Covid-19.N Engl J Med. 2020 Nov 12;383(20):1992-1993. doi: 10.1056/NEJMc2030446. Epub 2020 Oct 27. N Engl J Med. 2020. PMID: 33108105 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources